Trending...
- Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
- ALight Technology And Services Limited Advances Through Peachscore + Dealum Accelerator and Join LvlUp Labs
- International Misophonia Foundation Launches Sensory Accessible Technology Initiative to Address Overlooked Digital Accessibility Barriers
INNOVATION PARK, N.C. ~ IQVIA Holdings Inc. (NYSE:IQV) announced today that its wholly-owned subsidiary, IQVIA Inc., has allocated a new term B loan due 2031 of approximately $1,500 million. This loan was upsized due to lender demand.
The proceeds from the new term loan B and the offering of $1,250 million in aggregate principal amount of senior secured notes due 2029 will be used to repay outstanding Euro-denominated and U.S.-denominated term B loans under the Borrower's senior secured credit facilities, as well as to pay fees and expenses related to the Borrower's Notes offering and the Borrower's credit agreement amendment in respect of the New Term Loan B.
In connection with the allocation of the New Term Loan B, IQVIA entered into a cross-currency swap agreement which will effectively convert the New Term Loan B into a euro-denominated borrowing at prevailing euro interest rates to hedge exposure to USD-denominated indebtedness created by the New Term Loan B. The effective net borrowing rate to IQVIA will be 4.9015%, inclusive of the yield on the New Term Loan B and the beneficial impact of the cross-currency swap.
More on ncarol.com
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to life sciences industry. It creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is also a global leader in protecting individual patient privacy by using a wide variety of privacy-enhancing technologies and safeguards while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with precise treatment paths for better outcomes.
The company's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances in an effort to advance their path toward cures.
The proceeds from the new term loan B and the offering of $1,250 million in aggregate principal amount of senior secured notes due 2029 will be used to repay outstanding Euro-denominated and U.S.-denominated term B loans under the Borrower's senior secured credit facilities, as well as to pay fees and expenses related to the Borrower's Notes offering and the Borrower's credit agreement amendment in respect of the New Term Loan B.
In connection with the allocation of the New Term Loan B, IQVIA entered into a cross-currency swap agreement which will effectively convert the New Term Loan B into a euro-denominated borrowing at prevailing euro interest rates to hedge exposure to USD-denominated indebtedness created by the New Term Loan B. The effective net borrowing rate to IQVIA will be 4.9015%, inclusive of the yield on the New Term Loan B and the beneficial impact of the cross-currency swap.
More on ncarol.com
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
- Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
- The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms
- Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
- Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to life sciences industry. It creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is also a global leader in protecting individual patient privacy by using a wide variety of privacy-enhancing technologies and safeguards while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with precise treatment paths for better outcomes.
The company's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances in an effort to advance their path toward cures.
Filed Under: Business
0 Comments
Latest on ncarol.com
- PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
- Tonight in Asheville: KayeDinero Drops "Underground" and Opens Beat Catalog
- KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
- Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
- New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
- Prince's Collaborator Shelby J To Be A Special Guest For "a Deadly Proposal" Red Carpet
- Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
- 7th Annual RACE INDUSTRY WEEK Returns Nov. 30 – Dec. 3 With Free Live Webinars From Racing Leaders
- Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
- IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
- AQUALIS of Morrisville, NC, Acquires Full Circle Environmental of Garner, NC
- FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
- Building a Technology Powerhouse-From AI Drones and Global Acquisitions to Defense, Enterprise Software and the Future of Autonomous Operations $ZENA
- Shelter Structures America backs MATRA Second Life Project to turn retired tent vinyl into homes for displaced families
- P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
- Logicraft Launches FuelDeck™, AI That Turns Aviation Fuel Tickets Into One Traceable Ledger
- Inaugural OC Tech Week Draws 3,000 From 12 Countries, Sends Finalist to $1M Startup World Cup
- Award-Winning American Hotelier Opens Art-Filled Luxury Cottage in Norfolk, England
- Young Author Taraji Jones Surpasses 100 Amazon Book Sales
- K2 Global / Ozi Amanat Named Among Top 100 AI Venture Capitalists in 2026